Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29626 - 29650 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Decitabine	Approved Investigational	HVCN1	84329	upregulated	decitabine results in increased expression of HVCN1 mRNA	12q24.11	A21915
Decitabine	Approved Investigational	ICAM2	3384	upregulated	decitabine results in increased expression of ICAM2 mRNA	17q23.3	A21919
Decitabine	Approved Investigational	ID1	3397	upregulated	decitabine results in increased expression of ID1 mRNA	20q11.21	A20985
Decitabine	Approved Investigational	ID2	3398	upregulated	decitabine results in increased expression of ID2 mRNA	2p25.1	A20985
Decitabine	Approved Investigational	ID3	3399	upregulated	decitabine results in increased expression of ID3 mRNA	1p36.12	A20985
Decitabine	Approved Investigational	ID4	3400	upregulated	decitabine results in increased expression of ID4 mRNA	6p22.3	A21919
Decitabine	Approved Investigational	IER3	8870	upregulated	decitabine results in increased expression of IER3 mRNA	6p21.33	A21968 A21978
Decitabine	Approved Investigational	IFI27	3429	upregulated	decitabine results in increased expression of IFI27 mRNA	14q32.12	A21915
Decitabine	Approved Investigational	IFITM3	10410	upregulated	decitabine results in increased expression of IFITM3 mRNA	11p15.5	A21912
Decitabine	Approved Investigational	IGFBP3	3486	upregulated	decitabine results in increased expression of IGFBP3 mRNA	7p12.3	A21919 A21912 A21963
Decitabine	Approved Investigational	IGFBP6	3489	upregulated	decitabine results in increased expression of IGFBP6 mRNA	12q13.13	A21917
Decitabine	Approved Investigational	IGFBP7	3490	upregulated	decitabine results in increased expression of IGFBP7 mRNA	4q12	A21919 A21985
Decitabine	Approved Investigational	IL13RA1	3597	upregulated	decitabine results in increased expression of IL13RA1 mRNA	Xq24	A21986
Decitabine	Approved Investigational	IL24	11009	upregulated	decitabine results in increased expression of IL24 mRNA	1q32.1	A21930
Decitabine	Approved Investigational	IL6	3569	upregulated	decitabine results in increased expression of IL6 mRNA	7p15.3	A21845
Decitabine	Approved Investigational	IL6R	3570	upregulated	decitabine results in increased expression of IL6R mRNA	1q21.3	A21919
Decitabine	Approved Investigational	IL6ST	3572	upregulated	decitabine results in increased expression of IL6ST mRNA	5q11.2	A21987
Decitabine	Approved Investigational	INSIG1	3638	downregulated	decitabine results in decreased expression of INSIG1 mRNA	7q36.3	A20985
Decitabine	Approved Investigational	INSIG2	51141	upregulated	decitabine results in increased expression of INSIG2 mRNA	2q14.1-q14.2	A20985
Decitabine	Approved Investigational	IRF1	3659	upregulated	decitabine results in increased expression of IRF1 mRNA	5q31.1	A21930
Decitabine	Approved Investigational	IRF7	3665	upregulated	decitabine results in increased expression of IRF7 mRNA	11p15.5	A21930
Decitabine	Approved Investigational	IRS2	8660	upregulated	decitabine results in increased expression of IRS2 mRNA	13q34	A21919
Decitabine	Approved Investigational	JAK3	3718	downregulated	decitabine results in decreased expression of JAK3 mRNA	19p13.11	A20849
Decitabine	Approved Investigational	JUP	3728	upregulated	decitabine results in increased expression of JUP mRNA	17q21.2	A21938 A21939
Decitabine	Approved Investigational	KAT5	10524	upregulated	decitabine results in increased expression of KAT5 mRNA	11q13.1	A21917

Displaying entries 29626 - 29650 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability